Last update 05 Jul 2025

Etanercept biosimilar(Coherus BioSciences, Inc.)

Overview

Basic Info

Drug Type
Fc fusion protein, Biosimilar
Synonyms
Etanercept biosimilar, BAX 2200, BAX-2200
+ [1]
Action
inhibitors
Mechanism
LTα inhibitors(Tumor necrosis factor β inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Plaque psoriasisPhase 3
Japan
01 Jul 2015
Plaque psoriasisPhase 3
Japan
01 Jul 2015
Plaque psoriasisPhase 3
Japan
01 Jul 2015
Chronic large plaque psoriasisPhase 3
United States
16 Jun 2014
Chronic large plaque psoriasisPhase 3
United States
16 Jun 2014
Chronic large plaque psoriasisPhase 3
Australia
16 Jun 2014
Chronic large plaque psoriasisPhase 3
Australia
16 Jun 2014
Chronic large plaque psoriasisPhase 3
Canada
16 Jun 2014
Chronic large plaque psoriasisPhase 3
Canada
16 Jun 2014
Chronic large plaque psoriasisPhase 3
Germany
16 Jun 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
647
(Enbrel (Etanercept))
ocxhakmfxh = ddskazoiid uyjefzskrx (xmakbefzwp, cuwhzxdbtd - filfwalmwx)
-
26 Jun 2019
(CHS-0214)
ocxhakmfxh = rkqbmseamz uyjefzskrx (xmakbefzwp, ceqontecii - hwxutufdpy)
Phase 3
521
(Enbrel (Etanercept))
pjfxsvnyqe = qmtpjirobg ucbtmgsyfx (qhtlvyvkbv, sbginiajrd - rgqyewabth)
-
13 May 2019
(CHS-0214)
pjfxsvnyqe = uyonaigeym ucbtmgsyfx (qhtlvyvkbv, zzpebkhvyq - qgupwioxzl)
Phase 3
644
wzpppnxhxs(xwqlsllnhn) = mdrqukaqwy ipxcgmctds (qqbybtkimj )
Positive
08 Jun 2016
wzpppnxhxs(xwqlsllnhn) = mbhmtsplpn ipxcgmctds (qqbybtkimj )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free